RhythmAnalytics vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Shenzhen Carewell Electronics Co.

AI Verdict

RhythmAnalytics specializes in AI-powered interpretation of cardiac arrhythmias from single-lead ECG data, ideal for integration into monitoring systems. AI-ECG Tracker provides a more comprehensive AI-driven auto-analysis and diagnosis for 12-lead ECG data, encompassing a broader range of cardiac abnormalities beyond just arrhythmias. While both operate in the Cardiology AI space, their specific focus on ECG lead types and diagnostic breadth makes them suitable for different clinical applications.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, real-time interpretation of cardiac arrhythmias from single-lead ECG data, especially for integration into remote patient monitoring systems or wearable devices. Its cloud-based API is ideal for developers seeking to enhance existing platforms with precise arrhythmia detection and clinical decision support.

View RhythmAnalytics →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your clinical practice requires comprehensive, high-accuracy AI-powered auto-diagnosis for 12-lead ECGs, encompassing not only arrhythmias but also conditions like myocardial ischemia and ventricular hypertrophy. This tool is best suited for on-premise deployment in a diagnostic setting where a dedicated workstation and professional client are preferred for detailed review and report generation.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics AI-ECG Tracker
Pricing Contact vendor Not publicly available
Deployment Cloud-based API On-premise (AI-ECG Workstation, Diagnostic Client) with optional cloud service (Lepu Nebula Cloud) for remote diagnostic services.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-ECG Tracker

Tool B offers a dedicated Windows-based professional ECG diagnostic client and a web-based management portal, suggesting a more complete and direct user interface for clinicians. In contrast, Tool A is primarily a cloud-based API designed for integration into existing healthcare solutions, implying less direct end-user interaction.

Clinical Value

AI-ECG Tracker

Tool B provides comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, and supports 12-lead ECG data. Tool A focuses on the detection of over 15 to 30 types of cardiac arrhythmias from single-lead ECG data, offering a narrower diagnostic scope.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly available pricing information. Both require contacting the vendor for details, making a direct comparison of their pricing and value propositions impossible.

Enterprise Readiness

RhythmAnalytics

Tool A is explicitly HIPAA compliant and offered as a cloud-based API (SaaS), which facilitates scalable integration into diverse enterprise healthcare IT environments. While Tool B offers a management portal and optional cloud services, its primary deployment includes an on-premise workstation, and its HIPAA and BAA compliance are stated as 'likely' rather than explicit, potentially adding complexity for some enterprise deployments.

Innovation

AI-ECG Tracker

Tool B positions itself as a pioneer in applying AI to ECG auto-diagnosis, offering high accuracy for a broad spectrum of cardiac abnormalities, including myocardial ischemia and infarction, and supports 12-lead ECG data with rapid diagnosis in approximately 3 seconds. While Tool A utilizes advanced deep learning for arrhythmia detection, Tool B's wider diagnostic range and comprehensive approach suggest a broader innovative impact in ECG analysis.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded specific information regarding the availability, scope, or quality of support channels or documentation for either Tool A or Tool B. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics AI-ECG Tracker
Product Name RhythmAnalytics AI-ECG Tracker
Company Biofourmis Singapore Pte. Shenzhen Carewell Electronics Co.
Core Functionality AI-powered automated interpretation of cardiac arrhythmias for clinical decision support. AI-powered ECG auto-analysis and diagnosis for common cardiac abnormalities.
ECG Lead Support Single-lead ECG data Supports 12-lead ECG data collection
Specific Conditions Detected Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) 16 cardiac classifications and 104 ECG diagnostic classifications (including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction)

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics is designed for automated interpretation of cardiac arrhythmias from single-lead ECG data. In contrast, AI-ECG Tracker supports 12-lead ECG data collection for its auto-analysis and diagnosis capabilities.
RhythmAnalytics provides automated interpretation for over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. AI-ECG Tracker offers comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, encompassing arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
RhythmAnalytics offers AI-based automated interpretation of cardiac arrhythmias, including beat-by-beat morphology computation, QRS and Ventricular Ectopic Beat detection, and interval measurement. AI-ECG Tracker provides AI-powered ECG auto-analysis and diagnosis with high accuracy for common cardiac abnormalities, a powerful GPU for fast computing, and a professional diagnostic client for review and report generation.
AI-ECG Tracker boasts a rapid diagnosis time of approximately 3 seconds. The specific speed of analysis for RhythmAnalytics is not specified in the provided information.
AI Tool Finder
AI-powered search. Results may not be comprehensive.